Hormonal Therapy in Cancer Treatment: Eligibility, Types & Key Benefits

Have you ever wondered why two people diagnosed with the same cancer are treated no differently and why one may need tablets for five to ten years while the other doesn’t?

The answer lies in tumour biology. Some cancers do not simply grow on their own; they grow because they are fuelled by hormones circulating in the body. When hormones drive cancer growth, blocking that fuel can dramatically improve outcomes.

Globally, breast cancer remains the most commonly diagnosed cancer, with over 2.3 million new cases reported in 2022. Nearly 70–80% of breast cancers are hormone receptor-positive, meaning they depend on estrogen or progesterone to grow. Clinical research shows that 5 years of hormonal therapy, such as tamoxifen, can reduce recurrence by about 40% and mortality by roughly 30% in these patients.

Prostate cancer, with approximately 1.4 million new cases worldwide, is also frequently hormone-driven, relying on testosterone to grow. These figures highlight why hormonal cancer therapy is not simply supportive care; it is a scientifically proven, life-extending treatment strategy.

What Is Hormonal Therapy for Cancer?

Hormonal therapy (also called endocrine therapy) is used to treat cancers that rely on hormones for growth.

Unlike chemotherapy, which directly destroys rapidly dividing cells, hormonal therapy works by:

• Lowering hormone production
• Blocking hormone receptors on cancer cells
• Preventing hormones from stimulating tumour growth

This explains how hormonal therapy works in cancer; it removes or blocks the biological signals that encourage tumour progression.

It is primarily used in:

• Hormone therapy for breast cancer
• Hormone therapy for prostate cancer
• Certain uterine or ovarian cancers

However, proper hormone receptor testing is essential before starting treatment.

Who Needs Hormone Therapy for Cancer?

Hormone-Receptor Positive Breast Cancer

If breast cancer cells test positive for estrogen or progesterone receptors (ER/PR positive), hormonal therapy is usually recommended.

It may be prescribed:

• After surgery to reduce recurrence
• Following chemotherapy or radiation
• In advanced cancer, to control the spread
• As long-term preventive therapy

Because most breast cancers are hormone-sensitive, treatment often continues for 5–10 years to maximise survival benefits.

Prostate Cancer

Prostate cancer cells commonly depend on testosterone.

Hormone therapy for prostate cancer, known as Androgen Deprivation Therapy (ADT), reduces testosterone production or blocks its action.

It is used:

• In advanced or metastatic disease
• Before or after radiation therapy
• When cancer returns after initial treatment
• In high-risk cases

Hormonal suppression significantly delays tumour progression and improves symptom control in hormone-sensitive prostate cancer.

Selected Gynaecological Cancers

Certain uterine and ovarian cancers may respond to hormonal therapy if testing confirms hormone receptor positivity. In these cases, endocrine therapy can help slow disease progression.

Types of Hormonal Therapy for Cancer

Understanding the types of hormonal therapy for cancer helps patients feel informed and empowered.

• Selective Estrogen Receptor Modulators (SERMs)
  Example: Tamoxifen blocks estrogen receptors on cancer cells.
• Aromatase Inhibitors
  Examples: Letrozole and Anastrozole reduce estrogen production in postmenopausal women.
• Androgen Deprivation Therapy (ADT)
  Reduces testosterone levels in prostate cancer patients.
• LHRH Agonists and Antagonists
  Interrupt hormone signalling from the brain.

Treatment selection depends on tumour biology, patient age, menopausal status, cancer stage, and overall health.

Benefits of Hormonal Therapy in Cancer

The benefits of hormonal therapy in cancer are well established through decades of research.

• Reduces Recurrence Risk: In breast cancer, recurrence risk can decrease by nearly 40% with appropriate therapy.
• Improves Survival: Mortality reduction of around 30% has been observed in certain hormone receptor-positive breast cancer patients.
• Slows Disease Progression: In prostate cancer, ADT significantly delays cancer growth.
• Better Tolerability: Many hormonal therapies are oral medications and generally better tolerated than chemotherapy.
• Long-Term Disease Control: In advanced cases, hormonal therapy can keep cancer controlled for years.

Side Effects of Hormonal Therapy

Like any medical treatment, there are possible side effects of hormonal therapy, although many are manageable.

Common effects include:

• Hot flashes
• Fatigue
• Mood changes
• Bone thinning (osteoporosis)
• Joint stiffness
• Reduced libido

Regular monitoring by an experienced oncology team helps manage these effects effectively and safely.

When Is Hormonal Therapy Not Recommended?

Hormonal therapy is not suitable for every cancer patient. If tumour testing shows that the cancer cells lack hormone receptors, endocrine therapy will not be effective.

It may also be avoided or adjusted in patients with certain pre-existing medical conditions, such as severe osteoporosis or cardiovascular risks. This is why determining who needs hormone therapy for cancer requires careful evaluation by a qualified oncology specialist.

At advanced oncology centres, treatment decisions are made after multidisciplinary review, ensuring therapy is both safe and appropriate.

Conclusion

Hormonal therapy represents one of the most powerful examples of personalised cancer care. Rather than treating all cancers the same way, it targets the biological drivers behind hormone-dependent tumours.

At Sparsh Hospital, patients benefit from comprehensive oncology care supported by advanced diagnostics and evidence-based treatment protocols. As a trusted centre for cancer treatment, Sparsh Hospital offers personalised strategies whether it involves hormone therapy for breast cancer, hormone therapy for prostate cancer, or managing long-term endocrine therapy safely.

Choosing the Best Oncology Hospital in Bangalore ensures access to experienced specialists and modern cancer therapies.

Consulting a skilled oncologist in Bangalore can help determine whether hormonal therapy is the right step toward improved survival and quality of life. Cancer care today is precise, personalised, and biology-driven, and when hormones are part of the story, targeted treatment can make all the difference.

Frequently Asked Questions

1) How long does hormonal cancer therapy usually continue?

Most breast cancer patients take hormonal therapy for 5–10 years to reduce recurrence risk. In prostate cancer, duration depends on stage, response, and overall treatment goals.

2) Is hormonal therapy suitable for all cancer patients?

No, hormonal therapy is effective only in cancers proven to be hormone-sensitive after receptor testing. If tumours lack hormone receptors, other treatment approaches are recommended.

3) Can hormonal therapy prevent cancer recurrence?

Yes, in hormone receptor-positive cancers, endocrine therapy significantly lowers recurrence risk when taken consistently. It is often a key component of long-term survival planning.

4) Are the side effects of hormonal therapy permanent?

Most side effects are manageable and may improve after treatment completion. Regular monitoring and supportive care help reduce long-term complications.

5) Can hormonal therapy be combined with other treatments?

Yes, it is commonly combined with surgery, chemotherapy, radiation, or targeted therapy. Combination strategies often provide the best overall treatment outcomes.